JP Stock MarketDetailed Quotes

4594 BrightPath Biotherapeutics

Watchlist
  • 44
  • -2-4.35%
20min DelayNot Open Dec 20 15:30 JST
3.75BMarket Cap-2.42P/E (Static)

BrightPath Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
-98.64%72K
-90.20%5K
-99.54%23K
-61.64%28K
-84.91%16K
-65.73%5.28M
-99.66%51K
7,437.31%5.05M
43.14%73K
-50.00%106K
Cost of revenue
-99.05%18K
-99.67%2K
-99.60%5K
-61.11%7K
-84.62%4K
-42.87%1.9M
-81.05%613K
7,182.35%1.24M
50.00%18K
-50.94%26K
Gross profit
-98.40%54K
100.71%4K
-99.55%17K
-61.82%21K
-84.81%12K
-72.01%3.38M
-104.75%-562K
7,524.00%3.81M
44.74%55K
-50.31%79K
Operating expense
-21.44%1.16B
-16.21%207.91M
-4.91%396.62M
-0.98%257.16M
-46.21%293.45M
-1.19%1.47B
-40.09%248.13M
18.40%417.12M
-18.57%259.7M
35.45%545.5M
Operating profit
21.27%-1.16B
16.40%-207.91M
4.04%-396.6M
0.97%-257.14M
46.20%-293.44M
0.61%-1.47B
38.19%-248.69M
-17.33%-413.3M
18.58%-259.64M
-35.48%-545.42M
Net non-operating interest income (expenses)
35.04%-1.39M
-1,598.78%-1.39M
0
101.35%6K
0
15.68%-2.14M
92.65%-82K
-991K
47.89%-445K
-9.79%-617K
Non-operating interest income
-40.00%12K
-33.33%6K
--0
----
----
-25.93%20K
-30.77%9K
--0
----
----
Non-operating interest expense
--0
----
----
----
----
-83.15%61K
----
----
----
----
Total other finance cost
-33.19%1.4M
----
----
----
----
-4.69%2.09M
-96.09%30K
--991K
-47.47%456K
9.79%617K
Net investment income
44.86%-2.66M
-167.29%-2.15M
431.25%680K
67.17%-564K
74.22%-626K
-38.96%-4.82M
67.76%-804K
135.75%128K
-1,180.50%-1.72M
-212.48%-2.43M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
27.17%-7.25M
74.97%-2.49M
-3.35M
0
-1.41M
-5,822.99%-9.96M
-1,088.88%-9.96M
0
0
0
Less:Write off
-27.17%7.25M
-74.97%2.49M
--3.35M
--0
--1.41M
74.67%9.96M
2,178.72%9.96M
--0
--0
--0
Other non-operating income (expenses)
-18.67%196K
140.98%100K
-90K
0
-24.70%186K
170.79%241K
-244K
0
561.11%238K
2,987.50%247K
Income before tax
21.40%-1.17B
17.68%-213.84M
3.57%-399.37M
1.48%-257.69M
46.14%-295.28M
-0.13%-1.48B
35.84%-259.78M
-16.95%-414.17M
18.34%-261.57M
-36.24%-548.22M
Income tax
0.00%1.9M
0.00%475K
0.00%475K
0.00%475K
0.00%475K
-21.49%1.9M
-21.49%475K
-21.49%475K
-21.49%475K
-21.49%475K
Net income
21.37%-1.17B
17.65%-214.32M
3.57%-399.84M
1.48%-258.17M
46.10%-295.76M
-0.10%-1.49B
35.82%-260.25M
-16.88%-414.64M
18.35%-262.05M
-36.16%-548.7M
Net income continuous operations
21.37%-1.17B
17.65%-214.32M
3.57%-399.84M
1.48%-258.17M
46.10%-295.76M
-0.10%-1.49B
35.82%-260.25M
-16.88%-414.64M
18.35%-262.05M
-36.16%-548.7M
Noncontrolling interests
Net income attributable to the company
21.37%-1.17B
17.65%-214.32M
3.57%-399.84M
1.48%-258.17M
46.10%-295.76M
-0.10%-1.49B
35.82%-260.25M
-16.88%-414.64M
18.35%-262.05M
-36.16%-548.7M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
21.37%-1.17B
17.65%-214.32M
3.57%-399.84M
1.48%-258.17M
46.10%-295.76M
-0.10%-1.49B
35.82%-260.25M
-16.88%-414.64M
18.35%-262.05M
-36.16%-548.7M
Gross dividend payment
Basic earnings per share
26.87%-18.21
23.06%-3.07
5.66%-6.33
7.64%-4.11
51.79%-4.7
12.78%-24.9
47.43%-3.99
0.74%-6.71
29.03%-4.45
-22.95%-9.75
Diluted earnings per share
26.87%-18.21
25.81%-3.07
5.66%-6.33
7.64%-4.11
51.79%-4.7
12.78%-24.9
45.48%-4.1381
0.91%-6.71
29.03%-4.45
-22.95%-9.75
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Total revenue -98.64%72K-90.20%5K-99.54%23K-61.64%28K-84.91%16K-65.73%5.28M-99.66%51K7,437.31%5.05M43.14%73K-50.00%106K
Cost of revenue -99.05%18K-99.67%2K-99.60%5K-61.11%7K-84.62%4K-42.87%1.9M-81.05%613K7,182.35%1.24M50.00%18K-50.94%26K
Gross profit -98.40%54K100.71%4K-99.55%17K-61.82%21K-84.81%12K-72.01%3.38M-104.75%-562K7,524.00%3.81M44.74%55K-50.31%79K
Operating expense -21.44%1.16B-16.21%207.91M-4.91%396.62M-0.98%257.16M-46.21%293.45M-1.19%1.47B-40.09%248.13M18.40%417.12M-18.57%259.7M35.45%545.5M
Operating profit 21.27%-1.16B16.40%-207.91M4.04%-396.6M0.97%-257.14M46.20%-293.44M0.61%-1.47B38.19%-248.69M-17.33%-413.3M18.58%-259.64M-35.48%-545.42M
Net non-operating interest income (expenses) 35.04%-1.39M-1,598.78%-1.39M0101.35%6K015.68%-2.14M92.65%-82K-991K47.89%-445K-9.79%-617K
Non-operating interest income -40.00%12K-33.33%6K--0---------25.93%20K-30.77%9K--0--------
Non-operating interest expense --0-----------------83.15%61K----------------
Total other finance cost -33.19%1.4M-----------------4.69%2.09M-96.09%30K--991K-47.47%456K9.79%617K
Net investment income 44.86%-2.66M-167.29%-2.15M431.25%680K67.17%-564K74.22%-626K-38.96%-4.82M67.76%-804K135.75%128K-1,180.50%-1.72M-212.48%-2.43M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) 27.17%-7.25M74.97%-2.49M-3.35M0-1.41M-5,822.99%-9.96M-1,088.88%-9.96M000
Less:Write off -27.17%7.25M-74.97%2.49M--3.35M--0--1.41M74.67%9.96M2,178.72%9.96M--0--0--0
Other non-operating income (expenses) -18.67%196K140.98%100K-90K0-24.70%186K170.79%241K-244K0561.11%238K2,987.50%247K
Income before tax 21.40%-1.17B17.68%-213.84M3.57%-399.37M1.48%-257.69M46.14%-295.28M-0.13%-1.48B35.84%-259.78M-16.95%-414.17M18.34%-261.57M-36.24%-548.22M
Income tax 0.00%1.9M0.00%475K0.00%475K0.00%475K0.00%475K-21.49%1.9M-21.49%475K-21.49%475K-21.49%475K-21.49%475K
Net income 21.37%-1.17B17.65%-214.32M3.57%-399.84M1.48%-258.17M46.10%-295.76M-0.10%-1.49B35.82%-260.25M-16.88%-414.64M18.35%-262.05M-36.16%-548.7M
Net income continuous operations 21.37%-1.17B17.65%-214.32M3.57%-399.84M1.48%-258.17M46.10%-295.76M-0.10%-1.49B35.82%-260.25M-16.88%-414.64M18.35%-262.05M-36.16%-548.7M
Noncontrolling interests
Net income attributable to the company 21.37%-1.17B17.65%-214.32M3.57%-399.84M1.48%-258.17M46.10%-295.76M-0.10%-1.49B35.82%-260.25M-16.88%-414.64M18.35%-262.05M-36.16%-548.7M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 21.37%-1.17B17.65%-214.32M3.57%-399.84M1.48%-258.17M46.10%-295.76M-0.10%-1.49B35.82%-260.25M-16.88%-414.64M18.35%-262.05M-36.16%-548.7M
Gross dividend payment
Basic earnings per share 26.87%-18.2123.06%-3.075.66%-6.337.64%-4.1151.79%-4.712.78%-24.947.43%-3.990.74%-6.7129.03%-4.45-22.95%-9.75
Diluted earnings per share 26.87%-18.2125.81%-3.075.66%-6.337.64%-4.1151.79%-4.712.78%-24.945.48%-4.13810.91%-6.7129.03%-4.45-22.95%-9.75
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Wintest
6721
127 +30.93%
Showcase
3909
349 +29.74%
Beauty Kadan Holdings
3041
417 +23.74%
Cybozu
4776
2644 +23.32%
KODAMA CHEMICAL INDUSTRY
4222
440 +22.22%

See the daily top gainer.